BlackRock Valuation
Is BLK * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
1/6Valuation Score 1/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of BLK * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: BLK * (MX$14436.5) is trading above our estimate of fair value (MX$9925.6)
Significantly Below Fair Value: BLK * is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for BLK *?
Other financial metrics that can be useful for relative valuation.
What is BLK *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$117.00b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 6.6x |
Enterprise Value/EBITDA | 17.2x |
PEG Ratio | 3.1x |
Price to Earnings Ratio vs Peers
How does BLK *'s PE Ratio compare to its peers?
Company | Forward PE | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 44.2x | ||
GPROFUT * Grupo Profuturo. de | 9.5x | n/a | Mex$27.1b |
GBM O Corporativo GBM. de | 75.8x | n/a | Mex$21.6b |
KKR KKR | 23.1x | 10.4% | US$93.4b |
BN Brookfield | 68.2x | n/a | CA$88.2b |
BLK * BlackRock | 19.8x | 6.3% | Mex$117.0b |
Price-To-Earnings vs Peers: BLK * is good value based on its Price-To-Earnings Ratio (19.8x) compared to the peer average (44.2x).
Price to Earnings Ratio vs Industry
How does BLK *'s PE Ratio compare vs other companies in the South American Capital Markets Industry?
Price-To-Earnings vs Industry: BLK * is expensive based on its Price-To-Earnings Ratio (19.8x) compared to the South American Capital Markets industry average (10.1x).
Price to Earnings Ratio vs Fair Ratio
What is BLK *'s PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PE Ratio | 19.8x |
Fair PE Ratio | n/a |
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate BLK *'s Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$14,436.50 | Mex$16,870.51 +16.9% | 7.8% | Mex$19,760.01 | Mex$13,961.28 | n/a | 15 |
Jun ’25 | Mex$12,870.00 | Mex$15,490.89 +20.4% | 7.8% | Mex$18,144.10 | Mex$12,819.57 | n/a | 15 |
May ’25 | Mex$13,152.80 | Mex$15,622.58 +18.8% | 7.7% | Mex$18,316.69 | Mex$12,941.51 | n/a | 16 |
Apr ’25 | Mex$13,650.00 | Mex$15,026.96 +10.1% | 6.9% | Mex$17,047.29 | Mex$12,340.57 | n/a | 17 |
Mar ’25 | Mex$13,866.00 | Mex$15,314.79 +10.4% | 7.5% | Mex$17,474.20 | Mex$12,513.23 | n/a | 15 |
Feb ’25 | Mex$13,131.00 | Mex$15,179.80 +15.6% | 9.2% | Mex$17,606.12 | Mex$12,195.46 | n/a | 16 |
Jan ’25 | Mex$13,635.01 | Mex$13,773.11 +1.0% | 9.1% | Mex$15,527.58 | Mex$12,027.93 | n/a | 15 |
Dec ’24 | Mex$13,023.00 | Mex$13,298.09 +2.1% | 8.4% | Mex$15,575.15 | Mex$11,720.43 | n/a | 15 |
Nov ’24 | Mex$11,132.13 | Mex$13,709.08 +23.1% | 8.5% | Mex$16,160.62 | Mex$12,161.00 | n/a | 15 |
Oct ’24 | Mex$11,395.00 | Mex$13,852.36 +21.6% | 6.4% | Mex$15,704.25 | Mex$12,106.42 | n/a | 15 |
Sep ’24 | Mex$12,200.00 | Mex$13,852.36 +13.5% | 6.4% | Mex$15,704.25 | Mex$12,106.42 | n/a | 15 |
Aug ’24 | Mex$12,348.00 | Mex$13,528.03 +9.6% | 7.3% | Mex$15,499.23 | Mex$11,830.58 | n/a | 15 |
Jul ’24 | Mex$11,904.16 | Mex$13,051.78 +9.6% | 10.7% | Mex$15,710.38 | Mex$9,255.46 | n/a | 16 |
Jun ’24 | Mex$11,800.00 | Mex$13,476.44 +14.2% | 10.7% | Mex$16,214.91 | Mex$9,552.70 | Mex$12,870.00 | 16 |
May ’24 | n/a | Mex$13,998.17 0% | 14.3% | Mex$19,414.30 | Mex$9,743.10 | Mex$13,152.80 | 17 |
Apr ’24 | Mex$11,975.11 | Mex$14,454.39 +20.7% | 13.2% | Mex$19,601.33 | Mex$10,660.37 | Mex$13,650.00 | 16 |
Mar ’24 | Mex$12,590.00 | Mex$14,844.19 +17.9% | 12.8% | Mex$19,879.44 | Mex$10,811.63 | Mex$13,866.00 | 16 |
Feb ’24 | Mex$14,165.00 | Mex$15,237.53 +7.6% | 12.7% | Mex$20,448.88 | Mex$11,121.32 | Mex$13,131.00 | 16 |
Jan ’24 | Mex$13,897.78 | Mex$14,239.65 +2.5% | 22.1% | Mex$23,553.52 | Mex$9,483.60 | Mex$13,635.01 | 15 |
Dec ’23 | Mex$13,840.00 | Mex$12,751.45 -7.9% | 15.0% | Mex$16,427.37 | Mex$9,339.91 | Mex$13,023.00 | 13 |
Nov ’23 | Mex$12,908.00 | Mex$12,642.76 -2.1% | 12.2% | Mex$15,219.99 | Mex$9,632.65 | Mex$11,132.13 | 13 |
Oct ’23 | Mex$11,149.00 | Mex$14,236.24 +27.7% | 13.5% | Mex$17,319.11 | Mex$10,733.82 | Mex$11,395.00 | 12 |
Sep ’23 | Mex$13,420.00 | Mex$14,222.83 +6.0% | 12.5% | Mex$17,063.43 | Mex$10,575.36 | Mex$12,200.00 | 12 |
Aug ’23 | Mex$13,595.00 | Mex$14,433.92 +6.2% | 11.1% | Mex$17,398.48 | Mex$10,909.87 | Mex$12,348.00 | 12 |
Jul ’23 | Mex$12,500.00 | Mex$15,584.91 +24.7% | 15.3% | Mex$19,544.39 | Mex$10,777.57 | Mex$11,904.16 | 12 |
Jun ’23 | Mex$13,031.00 | Mex$16,786.91 +28.8% | 8.7% | Mex$19,361.46 | Mex$14,620.69 | Mex$11,800.00 | 12 |
Analyst Forecast: Target price is less than 20% higher than the current share price.